As previously reported, Craig-Hallum upgraded QuidelOrtho to Buy from Hold with a price target of $57, up from $40. The firm believes the company has significant untapped earnings power, which will be unlocked over the course of the next several years. Further, Craig-Hallum thinks Quidel can generate mid-to-high single digit revenue growth, with mid-to-high 20s EBITDA margins by 2027. If right, EBITDA could be at least $750M in 2027, with an upside scenario of more than $850M, the firm adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL:
- QuidelOrtho upgraded to Buy from Hold at Craig-Hallum
- Jana added Rapid7 during Q2, sold out of Freshpet
- QuidelOrtho says ‘aggressively’ pursuing additional cost savings
- QuidelOrtho expects to be ‘at or slightly below’ previously stated FY24 guidance
- QuidelOrtho says underlying business stable, value proposition strong